Understanding how cannabinoid signals affect opioid use disorder
Chemical biology tools for illuminating cannabinoid signaling pathways in opioid use disorder.
This project aims to better understand how cannabinoid signals in the brain influence opioid use disorder, especially in the face of powerful synthetic opioids like fentanyl.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-11166582 on NIH RePORTER |
What this research studies
The ongoing opioid crisis, worsened by highly potent synthetic opioids like fentanyl, urgently needs new treatment approaches. Current medications that target opioid receptors directly are less effective against fentanyl's strong effects. This work explores cannabinoid receptors in the brain, which are found in the same areas as opioid receptors and may play a role in opioid reward behaviors. By developing new chemical biology methods, we can precisely observe and control these cannabinoid receptors to learn how they contribute to opioid use disorder. This deeper understanding is crucial for finding new ways to help people struggling with opioid addiction.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients but aims to benefit future patients with opioid use disorder by identifying new treatment strategies.
Not a fit: Patients not affected by opioid use disorder would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could uncover new targets for medications that help manage opioid use disorder, offering hope for more effective treatments.
How similar studies have performed: Previous studies suggest that cannabinoid receptors can influence opioid-related behaviors, but this project develops novel tools to overcome current limitations in understanding their precise roles.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Frank, James Allen — Oregon Health & Science University
- Study coordinator: Frank, James Allen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.